Can a healthy 63-year-old woman with normal laboratory values and normal renal function receive a 30 mg intramuscular dose of ketorolac (Toradol) on postoperative day 4?

Can a Healthy 63-Year-Old Female with Normal Renal Function Receive 30 mg IM Ketorolac on Postoperative Day 4?

Yes, a single 30 mg intramuscular dose of ketorolac on postoperative day 4 is appropriate for this patient, given her normal renal function and lack of contraindications, though the standard recommendation is to limit NSAID use to 48 hours postoperatively.

Clinical Reasoning

Duration of Ketorolac Use

The primary concern with your question is the timing rather than the dose or route. While 30 mg IM ketorolac is a standard and appropriate dose, most guidelines recommend limiting ketorolac use to 48 hours postoperatively 1. Day 4 falls outside this typical window, but this doesn't make it contraindicated—it simply requires careful consideration.

Safety Profile in This Patient Population

Renal Safety:

• Recent high-quality evidence from 2026 demonstrates that perioperative ketorolac (primarily as single 30 mg IV doses) was not associated with postoperative acute kidney injury in elderly patients (≥60 years) undergoing noncardiac surgery 2
• In patients with normal baseline renal function, ketorolac may actually be associated with a decreased risk of AKI (OR 0.6, P=0.03) 3
• The 2007 Cochrane review concluded that NSAIDs cause only a "clinically unimportant and transient reduction in renal function" in those with normal preoperative renal function 4

Critical caveat: These safety findings apply to patients with normal renal function. NSAIDs should absolutely not be administered to patients with preexisting renal insufficiency or estimated creatinine clearance below 50 mL/min 5.

Appropriate Dosing

The 30 mg IM dose is appropriate:

• Standard dosing ranges from 15-30 mg for parenteral ketorolac 6, 7
• Recent evidence suggests that doses of 15-20 mg are probably as effective as 30 mg or higher for pain relief 8
• The median dose used in the large elderly surgical cohort was 30 mg 2

Contraindications to Assess

Before administering, verify the patient does NOT have:

• History of atherothrombosis (peripheral artery disease, stroke, myocardial infarction) 5
• Preexisting renal dysfunction (creatinine clearance <50 mL/min) 5
• History of GI ulcer disease 4
• Concurrent use of anticoagulants at therapeutic doses (increases bleeding risk 2.5-fold) 5
• Signs of renal hypoperfusion 5
• Active bleeding concerns

Practical Recommendations

For this specific patient:

1. Verify normal renal function is current (not just historical)
2. Confirm adequate hydration status 9
3. Consider transitioning to oral NSAIDs instead, as the oral route should be favored when possible 5
4. Limit to short-term use: If NSAIDs are needed beyond day 4, do not exceed 7 days total duration 5
5. Use as part of multimodal analgesia: Combine with acetaminophen rather than relying on ketorolac alone 7, 5

Alternative Approach

Consider instead:

• Oral ibuprofen or oral ketorolac (if oral intake tolerated)
• Acetaminophen 1000 mg every 6-8 hours as first-line
• Reserve ketorolac for breakthrough pain not controlled by acetaminophen alone

Common Pitfalls to Avoid

1. Don't assume "healthy" means no cardiovascular risk: Even without documented atherothrombosis, a 63-year-old may have unrecognized cardiovascular disease
2. Don't ignore hydration status: Dehydration significantly increases NSAID-related renal risk
3. Don't combine with therapeutic anticoagulation: This substantially increases bleeding risk
4. Don't use routinely beyond 48 hours: While a single dose on day 4 is reasonable, establishing a pattern of extended NSAID use increases cumulative risk

Bottom line: A single 30 mg IM dose of ketorolac on postoperative day 4 is reasonable in this healthy patient with normal renal function, but strongly consider switching to oral NSAIDs or acetaminophen for ongoing pain management beyond this point.